Table 3.
Median OS stratified by age group, period and treatment modality
| Age group | Surgery and radiotherapy | Surgery, radiotherapy and chemotherapy | ||||
|---|---|---|---|---|---|---|
| Median OS, months (95% CI) | Median OS, months (95% CI) | |||||
| 1999–2005 | 2006–2010 | 2011–2014 | 1999–2005 | 2006–2010 | 2011–2014 | |
| 18–49 | 19.0 (18.0–21.0) | 23.0 (22.0–25.0) | 21.0 (19.0–22.0) | 21.0 (18.0–23.0) | 24.0 (22.0–26.0) | 20.0 (19.0–22.0) |
| 50–59 | 13.0 (13.0–14.0) | 17.0 (16.0–18.0) | 16.0 (15.0–17.0) | 14.0 (13.0–16.0) | 17.0 (16.0–18.0) | 16.0 (15.0–17.0) |
| 60–69 | 11.0 (10.0–11.0) | 13.0 (12.0–13.0) | 14.0 (13.0–14.0) | 13.0 (12.0–13.0) | 14.0 (13.0–14.0) | 14.0 (13.0–15.0) |
| 70–79 | 7.0 (7.0–8.0) | 8.0 (8.0–9.0) | 9.0 (9.0–9.0) | 10.0 (8.0–12.0) | 10.0 (9.0–11.0) | 11.0 (10.0–11.0) |
| ≥ 80 | 5.0 (4.0–6.0) | 6.0 (5.0–7.0) | 6.0 (5.0–8.0) | 6.0 (2.0–18.0) | 7.0 (5.0–9.0) | 7.0 (5.0–11.0) |
OS overall survival, CI confidence interval